Table 1.
The demographic details of pediatric (PS) and adolescent and adult (AA) subjects of four treatment arms (Test-PS and Placebo-PS; Test-AA and Placebo-AA) participated in the current clinical trial and their descriptive statistics.
| Parameters | Pediatric group (PS) |
P value [95% CI] (p < 0.05) | Adolescent and adult group (AA) |
P value [95% CI] (p < 0.05) | ||
|---|---|---|---|---|---|---|
| Test-PS | Placebo-PS | Test-AA | Placebo-AA | |||
| Subjects number (n) |
30 |
30 |
30 |
30 |
||
| Gender [n (%)] | ||||||
| Male | 12 (40.00%) | 8 (26.67%) | 23 (76.67%) | 22 (73.33%) | ||
| Female | 18 (60.00%) | 22 (73.33%) | 7 (23.33%) | 8 (26.67%) | ||
| Age (years) [min/max] | 4.89 ± 1.65 [2.10/7.30] | 5.28 ± 1.08 [3.00/7.50] | 0.283 [-0.331, 1.111] | 26.67 ± 16.03 [12.00/62.00] | 27.07 ± 17.41 [12.00/62.00] | 0.926 [-8.249, 9.049] |
| Height (cm) [min/max] | 99.95 ± 12.87 [63.50/121.00] | 106.48 ± 14.97 [80.00/125.00] | 0.075 [-0.689, 3.745] | 159.53 ± 11.23 [139.00/176.00] | 159.10 ± 11.10 [136.00/174.00] | 0.882 [-6.201, 5.341] |
| Weight (kg) [min/max] | 18.54 ± 5.31 [10.70/29.80] | 19.25 ± 3.98 [11.00/27.20] | 0.560 [-1.715, 3.135] | 61.43 ± 15.24 [32.00/86.00] | 60.80 ± 17.38 [34.00/97.00] | 0.882 [-9.078, 7.818] |
| Body Mass Index (kg m−2) [min/max] | 18.61 ± 4.47 [10.70/27.50] | 17.02 ± 3.22 [12.00/24.90] | 0.119 [-3.603, 0.423] | 23.53 ± 3.13 [14.60/28.07] | 23.21 ± 3.87 [15.40/32.00] | 0.726 [-2.139, 1.499] |
Values expressed as mean ± SD and the difference between two mean is reported with 95% Confidence Interval (CI).